mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.008 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.009 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |